Urine Methylation Markers in UTUC

Running, not enrolling · Not applicable

Conditions studied: Upper Tract Urothelial Cancer

In brief

This is a research study to measure DNA markers in the urine of patients with upper tract urothelial cancer (UTUC) before surgery and during follow-up visits. Identifying these DNA markers could improve diagnosis before surgery, help assess risk, and predict early recurrence of the cancer. Urine samples will be de-identified and sent to Pangea Laboratory LLC for analysis. The results of this test will be compared to the traditional tests in upper tract urothelial cancer, such as cells in the urine and tissue biopsy.

Key facts

Study ID

NCT06805630

Run by

Duke University

People needed

50

Starts

2025-05-07

Expected to finish

2026-12-30

Last updated by the study team

2026-08-05

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• >=18 years
• Primary UTUC

You may not qualify if…

• Patients who do not understand and/or are unwilling to sign a written informed consent

Where it is running

• Duke University — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.